iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Cardiomyopathy (Dilated)

Cardiomyopathy (Dilated)

Management of dilated cardiomyopathy.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Cardiology

Clinical Guidelines

2023 ESC Guidelines for the management of cardiomyopathies
National
Chronic heart failure in adults: diagnosis and management
National
NICE guideline [NG106]: Chronic heart failure in adults: diagnosis and management
National
2016 ESC Position Statement on Genetic Counselling and Testing in Cardiomyopathies
Local
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
Local
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Local

Recent iatroX Q&As

  • What are the current guidelines for the pharmacological management of dilated cardiomyopathy in adults?Updated: 8/16/2025
  • When should I consider referring a patient with dilated cardiomyopathy to a cardiologist?Updated: 8/16/2025
  • How can I effectively monitor the progression of dilated cardiomyopathy in my patients?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play